Clinical Trial

A Pilot Effectiveness and Implementation Trial of CSNAT-I in Hong Kong

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this hybrid Type 1 effectiveness-implementation pilot randomized controlled trial, 60 caregivers will be randomized into either the CSNAT-I group or usual care. Preliminary effectiveness outcomes include caregiver burden, distress, and health-related quality of life. Preliminary implementation outcomes include feasibility, fidelity, appropriateness, acceptability, cost of the intervention, as well as barriers and facilitators to intervention implementation. Quantitative data will be analyzed using descriptive analysis and linear mixed effects model, while qualitative data using thematic analysis. The CSNAT-I is expected to be preliminarily effective in improving caregiver outcomes and implementable in Hong Kong palliative care context, which will serve as the foundation for a large trial before integration into daily practice.
Trial Details
NCT Number NCT07193433
Lead Sponsor The Hong Kong Polytechnic University
Collaborators: United Christian Hospital, Haven of Hope Hospital
Conditions Carers, Palliative Care, Needs Assessment, Supportive Care
Enrollment 60 participants
Start Date 2025-09-20
Primary Completion 2026-03-20 (estimated)
Study Completion 2026-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-09-25